A "highly mutated" COVID-19 variant has been found in several states across the country, including Texas. The variant BA.3.2, also nicknamed "Cicada," is steadily rising in U.S. cases after it was ...

ROANOKE, Va. (WDBJ) - A severe case of COVID-19 or the flu could raise the risk of developing lung cancer, according to a new study from the University of Virginia. Researchers found that after a ...

“We’re seeing a lot of cases of norovirus (stomach flu) right now. It spreads quickly in schools, nursing homes, and households. Younger children and older adults are especially vulnerable and can ...

New research from UVA Health finds severe COVID-19 and influenza can prime the lungs for cancer and speed the disease’s development, but vaccination can help prevent those effects. “A bad case of ...

Heard about a lot of people getting flu this winter but not much about covid? It’s not just you. For the second winter in a row, the United States has faced a punishing flu season, with covid as a ...

OKLAHOMA CITY (KFOR) — Spring feels like it is starting early, which would lead many to believe we are nearing the end of cold and flu season. However, right now, Oklahoma ranks 4th in the country for ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...

European regulators gave the green light to Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled vaccine maker as it struggles to get the same shot approved in the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More children with vs. without OSA were diagnosed with ...

Moderna seeks to return to growth Its share price has lost 90% from pandemic peaks Anti-vaccine health secretary has disrupted US vaccine policy Feb 27 (Reuters) - Europe's medicines regulator ...

The European Medicines Agency (EMA) has recommended granting marketing authorization to the combined influenza and COVID-19 messenger RNA (mRNA) vaccine, mCombriax (Moderna), for people aged 50 years ...

A single spritz could eventually offer simultaneous protection against several infectious diseases. Researchers at Stanford Medicine have developed a new vaccine that could prevent multiple viruses at ...